Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.3M Sell
293,100
-185,200
-39% -$22.5M 0.01% 1765
2025
Q4
$52.3M Buy
478,300
+249,200
+109% +$36.2M 0.01% 1576
2025
Q3
$32.4M Sell
229,100
-177,000
-44% -$25.8M 0.01% 2049
2025
Q2
$65.7M Sell
406,100
-5,374
-1% -$667K 0.01% 1275
2025
Q1
$43.9M Buy
411,474
+109,512
+36% +$15.3M 0.01% 1600
2024
Q4
$37.3M Buy
301,962
+231,962
+331% +$32.7M 0.01% 1721
2024
Q3
$10M Sell
70,000
-29,400
-30% -$4.18M ﹤0.01% 2367
2024
Q2
$16.3M Sell
99,400
-66,600
-40% -$8.28M ﹤0.01% 1846
2024
Q1
$20.7M Buy
+166,000
New +$17.6M 0.01% 1655

Other funds holding ARM

UBS Group's ARM Position: Q1 2026 in Review

UBS Group reduced its Arm (ARM) stake by 0.01% in Q1 2026, selling an estimated $18.1K and leaving 1,677,045 shares worth $254M. The position accounts for 0.04% of the portfolio, ranked #503.

UBS Group first reported a position in ARM in Q3 2023 and has held it in 11 quarters since. The position peaked at $533M in Q2 2025. 742 funds tracked by Wall St. Rank hold ARM as of Q1 2026.

  • UBS Group held 1,677,045 shares of Arm worth $254M as of Q1 2026.
  • UBS Group sold 149 Arm shares in Q1 2026, an estimated $18.1K.
  • Arm made up 0.04% of UBS Group's portfolio in Q1 2026, its #503 holding.
  • UBS Group first reported a position in Arm in Q3 2023 and has held it in 11 quarters since.
  • UBS Group's Arm position peaked at $533M in Q2 2025.
  • 742 funds tracked by Wall St. Rank held Arm as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.